This roundtable brought together a diverse group of experts from a range of backgrounds to discuss topics relevant to HIV where a multi-stakeholder approach, including industry, may lead to new and innovative solutions.
This IDPC briefing paper analyses some of the consequences of the current Brazilian drug policy, taking into account its impacts on prisoners’ rights and on the criminal justice system as a whole.
This IDPC report provides an overview and analysis of the key debates and discussions that took place during this year's CND, in particular in light of the approaching UNGASS.
In its latest report, the EU drugs agency (EMCDDA) looks at drugs in cities across Europe, revealing how some cities are developing drug strategies of their own.
This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new psychoactive substances.
The World Drug Report presents a comprehensive annual overview of the latest developments in the world's illicit drug markets by focusing on the production, trafficking and consumption of the main types of illicit drugs, along with the related health consequences of those drugs.
Despite some improvements, drug policy in Malaysia continues to include imprisonment of people who use drugs (PWUD), judicial corporal punishment, and compulsory detention, representing clear challenges to effective harm reduction service delivery.
This study is the first and only barometer report fully dedicated to drug policy in Latin America and is carried out in conjunction with key research centers in the region.
With the adoption of the Sustainable Development Goals, 2016 should be a defining moment for global health and for the response to the human immunodeficiency virus (HIV) epidemic, especially for the migrants in Central Asia.
Both in the UK and Australia, the use of police stop and search powers has raised concerns because of their overwhelming focus on members of black and minority ethnic communities.
A team of experts from the ECDPC and the EMCDDA confirmed the very high rate of infections with hepatitis B and C, HIV, and AIDS, concentrated mainly among certain populations at higher risk, and prepared a comprehensive list of remedial actions.
